期刊文献+

血清sFlt-1/PLGF比值在子痫前期患者诊断及预后判断中的价值 被引量:14

原文传递
导出
摘要 目的通过检测妊娠期高血压疾病患者血清中s Flt-1、PLGF浓度,探讨s Flt-1/PLGF比值在子痫前期患者临床中的可能应用价值。方法选择2013年3月-2014年10月苏州大学附属第一医院收治的子痫前期患者,其中早发型(Early onset preeclampsia,E-PE)30例,晚发型(Late onset preeclampsia,L-PE)58例,妊娠期高血压(Gestational Hypertension,GH)25例。并选择同孕周对照组孕妇50例,检测她们血清中s Flt-1、PLGF浓度,分析s Flt-1/PLGF比值的变化,并将其与新生儿出生体重行相关性分析,并利用其作为早发型子痫前期的诊断指标进行ROC曲线分析。结果血清标本中s Flt-1、PLGF的检测结果示早发型子痫前期患者血清中s Flt-1/PLGF比值明显高于其他各组并且与新生儿出生体重呈负相关,将该比值用作诊断指标时其曲线下面积为0.975。重度晚发型子痫前期s Flt-1/PLGF比值大于轻度晚发型子痫前期。所有子痫前期患者,随着母婴并发症总数增多s Flt-1/PLGF比值升高。结论 s Flt-1/PLGF比值对子痫前期患者病情严重程度评估及对早发型子痫前期的诊断具有重要价值,并且可用于预测新生儿出生体重。
作者 朱莹莹 黄沁
出处 《中国妇幼保健》 CAS 2016年第7期1528-1531,共4页 Maternal and Child Health Care of China
  • 相关文献

参考文献1

二级参考文献14

  • 1成春英,孙勇,文志斌,何晓凡,王谷丰,林国强,蒋海河,唐先明,贺石林.川芎嗪对凝血酶诱导血管内皮细胞组织因子表达的影响[J].南方医科大学学报,2009,29(8):1743-1747. 被引量:11
  • 2Craig Saffer,Gayle Olson,Kim A. Boggess,Richard Beyerlein,Charles Eubank,Baha M. Sibai.Determination of placental growth factor (PlGF) levels in healthy pregnant women without signs or symptoms of preeclampsia[J].Pregnancy Hypertension: An International Journal of Women’s Cardiovascular Health.2013(2)
  • 3Stefan Verlohren,Ignacio Herraiz,Olav Lapaire,Dietmar Schlembach,Manfred Moertl,Harald Zeisler,Pavel Calda,Wolfgang Holzgreve,Alberto Galindo,Theresa Engels,Barbara Denk,Holger Stepan.The sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients[J].American Journal of Obstetrics and Gynecology.2012(1)
  • 4Samantha J. Benton,Yuxiang Hu,Fang Xie,Kenneth Kupfer,Seok-Won Lee,Laura A. Magee,Peter von Dadelszen.Can placental growth factor in maternal circulation identify fetuses with placental intrauterine growth restriction?[J].American Journal of Obstetrics and Gynecology.2012(2)
  • 5Ulla B. Knudsen,Camilla S. Kronborg,Peter von Dadelszen,Ken Kupfer,Seok-Won Lee,Erik Vittinghus,Jim G. Allen,Christopher W. Redman.A single rapid point-of-care placental growth factor determination as an aid in the diagnosis of preeclampsia[J].Pregnancy Hypertension: An International Journal of Women’s Cardiovascular Health.2011(1)
  • 6Bahjat Al-Ani,Peter W. Hewett,Melissa J. Cudmore,Takeshi Fujisawa,Mahmoud Saifeddine,Hannah Williams,Wenda Ramma,Samir Sissaoui,Padma-Sheela Jayaraman,Motoi Ohba,Shakil Ahmad,Morley D. Hollenberg,Asif Ahmed.Activation of Proteinase-Activated Receptor 2 Stimulates Soluble Vascular Endothelial Growth Factor Receptor 1 Release via Epidermal Growth Factor Receptor Transactivation in Endothelial Cells[J].Hypertension.2010(3)
  • 7周琼,刘海意,曾万江,龚洵,吴媛媛,乔福元.缺氧调控滋养细胞和内皮细胞sFlt-1差异表达的研究[J].现代妇产科进展,2009,18(11):844-846. 被引量:5
  • 8崔世红,张林东.PLGF、Bcl-2及FasL在胎儿生长受限中的研究[J].中国妇幼保健,2010,25(24):3421-3423. 被引量:5
  • 9张正娥,王燕.川芎嗪对胎儿生长受限孕妇血液流变学的影响[J].中国医药导报,2012,9(5):51-53. 被引量:3
  • 10刘蔚,傅晓冬.子痫前期患者血清中sFlt-1水平的研究[J].泸州医学院学报,2012,35(2):169-171. 被引量:2

共引文献2

同被引文献143

  • 1Shu-Wei Li,Yi Ling,Song Jin,Ye-Fei Lin,Ze-Jun Chen,Chun-Xia Hu,Ming-Hua Wang,Mao-Zhong Yao.Expression of soluble vascular endothelial growth factor receptor-1 and placental growth factor in fetal growth restriction cases and intervention effect of tetramethylpyrazine[J].Asian Pacific Journal of Tropical Medicine,2014,7(8):663-667. 被引量:3
  • 2Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy [J]. Am J Obstet Gynecol, 2000,183(1):S1-S22.
  • 3Widmer M, Villar J, Benigni A, et al. Mapping tbe theories of preeclampsia and the role of angiogenic factors: a systematic review[J]. Obstet Gynecol, 2007,109(1):168-180. DOh 10.1097/01 .AOG.0000249609.04831.7c.
  • 4Robinson C J, Johnson DD. Soluble endoglin as a second-trimester marker for preeclampsia[J]. Am J Obstet Gynecol, 2007,197(2):174.el-5. DOh 10.1016/j.ajog.2007. 03.058.
  • 5Roberts JM, Hubel CA. The two stage model of preeclampsia: variations on the theme[J]. Placenta, 2009,30 Suppl A:S32-37. DOh lO.lO16/j.placenta.2008.11.009.
  • 6Nevo O, Soleymanlou N, Wu Y, et al. Increased expression of sFh-1 in in vivo and in vitro models of human placental hypoxia is mediated by HIF-I[J]. Am J Physiol Regul Integr Comp Physiol, 2006,291(4):R1085-1093. DOI: 10.1152/ ajpregu.O0794.2005.
  • 7Lash GE, Cartwright JE, Whitley GS, et al. The effects of angiogenic growth factors on extravillous trophoblast invasion and motility[J]. Placenta, 1999,20(8):661-667. DOh 10.1053/ plac. 1999,0427.
  • 8Redman CW, Sargent IL. Circulating micropartieles in normal pregnancy and pre-eclampsia[J]. Placenta, 2008,29 Suppl A: $73-77. DOh 10.1016/j.placenta.2007.11.016.
  • 9Rajakumar A, Michael HM, Rajakumar PA, et al.Extra-placental expression of vascular endothelial growth factor receptor-l, (Fit-l) and soluble Flt-1 (sFh-1), by peripheral blood mononuclear cells (PBMCs) in normotensive and preeclamptic pregnant women[J]. Placenta, 2005,26(7): 563-573. DOI: 10.1016/j.placenta.2004.09.001.
  • 10Nagamatsu T, Fujii T, Kusumi M, et al. Cytotrophoblasts up-regulate soluble fms-like tyrosine kinase-1 expression under reduced oxygen: an implication for the placental vascular development and the pathophysiology of preeclampsia [J]. Endocrinology, 2004,145(11):4838-4845. DOI: 10.1210/ en.2004-0533.

引证文献14

二级引证文献117

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部